3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
4
Phase 4
3
Phase NA
2
Phase 1
1
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Other hematologic neoplasm
2
Conditions
Leukemia, Myeloid, Acute
2
Mycoses
1
Genetic Predisposition to Disease
1
Candidiasis
1
Aspergillosis
1
Interventions
Cytarabine
19
Cyclophosphamide
18
venetoclax
15
fludarabine phosphate
14
Busulfan
14
Cyclosporine
12
Azacitidine
11
fludarabine
10
Peripheral Blood Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Mycophenolic Acid
9
Filgrastim
9
Melphalan
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Palliative Care
7
Idarubicin
6
Blood Specimen Collection
6
Methotrexate
5
Therapeutics
4
Specimen Handling
4
Radiotherapy
4
Methods
4
Early Intervention, Educational
4
Daunorubicin
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Tacrolimus
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myeloid, Acute
×
posaconazole
×
Clear all
NCT03828773
2025-12-09
PTX3AML
Centre Hospitalier Universitaire Vaudois
Phase NA
Recruiting
410 enrolled
NCT03796533
2022-02-24
Posa-Pk
Hospices Civils de Lyon
Phase NA
Unknown
120 enrolled